GIBU
WST icon

Gulf International Bank (UK)’s West Pharmaceutical WST Stock Holding History

Gulf International Bank (UK)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Sell
5,471
-147
-3% -$44.9K 0.04% 380
2026
Q1 		$1.41M Buy
5,618
+1,990
+55% +$495K 0.03% 441
2025
Q4 		$998K Hold
3,628
– – 0.03% 429
2025
Q3 		$952K Hold
3,628
– – 0.03% 444
2025
Q2 		$793K Hold
3,628
– – 0.03% 481
2025
Q1 		$812K Sell
3,628
-2,174
-37% -$599K 0.03% 483
2024
Q4 		$1.9M Sell
5,802
-57
-1% -$17.9K 0.05% 334
2024
Q3 		$1.76M Sell
5,859
-278
-5% -$85.1K 0.05% 349
2024
Q2 		$2.02M Hold
6,137
– – 0.05% 327
2024
Q1 		$2.43M Hold
6,137
– – 0.06% 293
2023
Q4 		$2.16M Sell
6,137
-618
-9% -$219K 0.06% 302
2023
Q3 		$2.53M Sell
6,755
-832
-11% -$322K 0.07% 273
2023
Q2 		$2.9M Sell
7,587
-2,100
-22% -$750K 0.07% 280
2023
Q1 		$3.36M Sell
9,687
-1,429
-13% -$418K 0.07% 292
2022
Q4 		$2.62M Hold
11,116
– – 0.05% 389
2022
Q3 		$2.73M Hold
11,116
– – 0.05% 359
2022
Q2 		$3.33M Hold
11,116
– – 0.06% 324
2022
Q1 		$4.57M Sell
11,116
-178
-2% -$69.7K 0.07% 291
2021
Q4 		$5.3M Sell
11,294
-2,522
-18% -$1.09M 0.07% 274
2021
Q3 		$5.87M Sell
13,816
-440
-3% -$185K 0.08% 272
2021
Q2 		$5.12M Sell
14,256
-60
-0.4% -$19.8K 0.06% 309
2021
Q1 		$4.03M Sell
14,316
-1,780
-11% -$509K 0.06% 356
2020
Q4 		$4.56M Sell
16,096
-1,270
-7% -$356K 0.06% 318
2020
Q3 		$4.77M Buy
17,366
+222
+1% +$58.8K 0.07% 278
2020
Q2 		$3.89M Hold
17,144
– – 0.06% 316
2020
Q1 		$2.61M Buy
17,144
+454
+3% +$69.9K 0.05% 356
2019
Q4 		$2.51M Buy
+16,690
New +$2.43M 0.04% 454

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Gulf International Bank (UK)'s WST Position: Q2 2026 in Review

Gulf International Bank (UK) reduced its West Pharmaceutical (WST) stake by 2.6% in Q2 2026, selling an estimated $44.9K and leaving 5,471 shares worth $1.96M. The position accounts for 0.04% of the portfolio, ranked #380.

Gulf International Bank (UK) first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.87M in Q3 2021. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Gulf International Bank (UK) held 5,471 shares of West Pharmaceutical worth $1.96M as of Q2 2026.
  • Gulf International Bank (UK) sold 147 West Pharmaceutical shares in Q2 2026, an estimated $44.9K.
  • West Pharmaceutical made up 0.04% of Gulf International Bank (UK)'s portfolio in Q2 2026, its #380 holding.
  • Gulf International Bank (UK) first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Gulf International Bank (UK)'s West Pharmaceutical position peaked at $5.87M in Q3 2021.
  • 833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.